BioCentury | Feb 13, 2020
Emerging Company Profile

Pneumagen: out-competing viral sugar binding to prevent infection

...sialic acid. Pneumagen is among a growing number of companies -- including Palleon Pharmaceuticals Inc., Tacalyx GmbH...
BioCentury | Sep 27, 2019
Finance

Via Munich office, Kurma launches oncology company Tacalyx

...underserved by VCs (see “Kurma’s Munich Move” ). Kurma and Boehringer Ingelheim Venture Fund co-led Tacalyx GmbH’s...
...around year end, with a target of about €150 million, Neubeck said. Paul Bonanos, Associate Editor Kurma Partners Tacalyx GmbH...
Items per page:
1 - 2 of 2
BioCentury | Feb 13, 2020
Emerging Company Profile

Pneumagen: out-competing viral sugar binding to prevent infection

...sialic acid. Pneumagen is among a growing number of companies -- including Palleon Pharmaceuticals Inc., Tacalyx GmbH...
BioCentury | Sep 27, 2019
Finance

Via Munich office, Kurma launches oncology company Tacalyx

...underserved by VCs (see “Kurma’s Munich Move” ). Kurma and Boehringer Ingelheim Venture Fund co-led Tacalyx GmbH’s...
...around year end, with a target of about €150 million, Neubeck said. Paul Bonanos, Associate Editor Kurma Partners Tacalyx GmbH...
Items per page:
1 - 2 of 2